Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cary N. Weiss
Observed name:
Cary Weiss
Institutions:
Brigham and Women's Hospital,
Boston Children's Hospital,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Observed institutions:
Boston University,
Brigham and Women's Hospital,
Boston Medical Center,
Boston Children's Hospital,
Albert Einstein College of Medicine,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
show all 8
ORCID:
0000-0001-7768-8956
Observed ORCID:
0000-0001-7768-8956
OpenAlex ID:
A5046172512
H1 histones control the epigenetic landscape by local chromatin compaction
2020
·
Michael A. Willcockson
, Sean E. Healton
, et al.
·
Nature
·
192
A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease
2017
·
Cary N. Weiss
, Keisuke Ito
·
International review of cytology
·
61
DNA Damage: A Sensible Mediator of the Differentiation Decision in Hematopoietic Stem Cells and in Leukemia
2015
·
Cary Weiss
, Keisuke Ito
·
International Journal of Molecular Sciences
·
31
PDF
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma
2025
·
Jiao Li
, Kaimeng Huang
, et al.
·
Nature Metabolism
·
24
microRNA-22 promotes megakaryocyte differentiation through repression of its target, GFI1
2019
·
Cary N. Weiss
, Keisuke Ito
·
Blood Advances
·
21
PDF
The role of PML in hematopoietic and leukemic stem cell maintenance
2014
·
Fumio Nakahara
, Cary N. Weiss
, et al.
·
International Journal of Hematology
·
19
PDF
DNA damage response, redox status and hematopoiesis
2013
·
Cary N. Weiss
, Keisuke Ito
·
Blood Cells Molecules and Diseases
·
19
Cancer target discovery enabled by transcriptome-based virtual CRISPR screening
2024
·
Ananthan Sadagopan
, Bingchen Li
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
6
TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma
2024
·
Jiao Li
, Kaimeng Huang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma
2026
·
Prathyusha Konda
, Alexandra J. Wakolbinger
, et al.
·
Nature Communications
·
2
PDF
An epigenetic bifunctional that toggles between transactivation and repression
2026
·
Ananthan Sadagopan
, Maximilian Carson
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Abstract PR006: Target discovery in rare cancers enabled by transcriptome-based virtual CRISPR screening
2026
·
Ananthan Sadagopan
, Bingchen Li
, et al.
·
Cancer Research
Abstract PR020: Targeting cadherin-17 in translocation renal cell carcinoma
2026
·
Prateek Khanna
, Jiao Li
, et al.
·
Cancer Research
Abstract B025: Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma
2026
·
Prathyusha Konda
, Cary Weiss
, et al.
·
Cancer Research
33fusion derived oncogenic programs shape the immune landscape in translocation renal cell carcinoma
2025
·
Prathyusha Konda
, Cary Weiss
, et al.
·
The Oncologist
PDF
Inflammation and Cytopenias in a Well-Appearing Infant With SARS-CoV-2
2021
·
Sabrina A. Karim
, Cary N. Weiss
, et al.
·
Clinical Pediatrics
Show more works
View as search
Works count:
17
Citation count:
381
H-index:
7
I10-index:
7
Year
Topic
Type
